Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

PAROXETINE HYDROCHLORIDE (ANHYDROUS) CRS (70 MG)

PAROXETINE HYDROCHLORIDE (ANHYDROUS) CRS (70 MG)

78246-49-8

DISCOVER
PAROXETINE HYDROCHLORIDE (ANHYDROUS) IMPURITY C CRS (10 MG)

PAROXETINE HYDROCHLORIDE (ANHYDROUS) IMPURITY C CRS (10 MG)

NA

DISCOVER
PAROXETINE IMPURITY E CRS (5 MG)

PAROXETINE IMPURITY E CRS (5 MG)

NA

DISCOVER
PAROXETINE HYDROCHLORIDE (ANHYDROUS) IMPURITY H CRS (15 MG)

PAROXETINE HYDROCHLORIDE (ANHYDROUS) IMPURITY H CRS (15 MG)

NA

DISCOVER
PREDNISOLONE ACETATE FOR PEAKIDENTIFICATION CRS (15 MG)

PREDNISOLONE ACETATE FOR PEAKIDENTIFICATION CRS (15 MG)

52-21-1

DISCOVER
VALERIAN DRY EXTRACT HRS (500MG)

VALERIAN DRY EXTRACT HRS (500MG)

06/10/3569

DISCOVER
VALNEMULIN HYDROCHLORIDE CRS (10 MG)

VALNEMULIN HYDROCHLORIDE CRS (10 MG)

133868-46-9

DISCOVER
VALNEMULIN FOR PEAK IDENTIFICATION CRS (20 MG)

VALNEMULIN FOR PEAK IDENTIFICATION CRS (20 MG)

NA

DISCOVER
VALNEMULIN IMPURITY E CRS (10MG)

VALNEMULIN IMPURITY E CRS (10MG)

125-65-5

DISCOVER
VENLAFAXINE HYDROCHLORIDE CRS(50 MG)

VENLAFAXINE HYDROCHLORIDE CRS(50 MG)

99300-78-4

DISCOVER
VENLAFAXINE FOR SYSTEM SUITABILITY CRS (1.002 MG)

VENLAFAXINE FOR SYSTEM SUITABILITY CRS (1.002 MG)

99300-78-4

DISCOVER
VINPOCETINE CRS (10 MG)

VINPOCETINE CRS (10 MG)

42971-09-5

DISCOVER